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Enterococci have emerged as important opportunistic pathogens in intensive care units
(ICUs). In this study, enterococcal population size and Enterococcus isolates colonizing
the intestinal tract of ICU patients receiving Selective Digestive Decontamination (SDD)
were investigated. All nine patients included in the study showed substantial shifts
in the enterococcal 16S rRNA gene copy number in the gut microbiota during
the hospitalization period. Furthermore, 41 Enterococcus spp. strains were isolated
and characterized from these patients at different time points during and after ICU
hospitalization, including E. faecalis (n = 13), E. faecium (n = 23), and five isolates that
could not unequivocally assigned to a specific species (E. sp. n= 5) Multi locus sequence
typing revealed a high prevalence of ST 6 in E. faecalis isolates (46%) and ST 117 in E.
faecium (52%). Furthermore, antibiotic resistance phenotypes, including macrolide and
vancomycin resistance, as well as virulence factor-encoding genes [asa1, esp-fm, esp-fs,
hyl, and cyl (B)] were investigated in all isolates. Resistance to ampicillin and tetracycline
was observed in 25 (61%) and 19 (46%) isolates, respectively. Furthermore, 30 out of 41
isolates harbored the erm (B) gene, mainly present in E. faecium isolates (78%). The most
prevalent virulence genes were asa1 in E. faecalis (54%) and esp (esp-fm, 74%; esp-fs,
39%). Six out of nine patients developed nosocomial enterococcal infections, however,
corresponding clinical isolates were unfortunately not available for further analysis. Our
results show that multiple Enterococcus species, carrying several antibiotic resistance
and virulence genes, occurred simultaneously in patients receiving SDD therapy, with
varying prevalence dynamics over time. Furthermore, simultaneous presence and/or
replacement of E. faecium STs was observed-, reinforcing the importance of screening
multiple isolates to comprehensively characterize enterococcal diversity in ICU patients.
Keywords: Enterococcus, intestinal colonization, antibiotic resistance, virulence factors, antibiotic prophylactic
therapy, selective digestive decontamination
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INTRODUCTION
The genus Enterococcus encompasses indigenous commensal
bacteria reported from the human and animal gut as well as
the oral cavity and vagina in humans, where they have adapted
to nutrient-rich, oxygen-depleted, and ecologically complex
environments (Fisher and Phillips, 2009).
In the human gut, the genus Enterococcus can constitute up to
1% of the total bacterial microbiota in healthy individuals, with
Enterococcus faecium and Enterococcus faecalis as most common
species (Sghir et al., 2000). In contrast to their commensal
role, over the past decades E. faecium and E. faecalis have also
emerged as agents of nosocomial infections such as endocarditis,
bacteraemia, meningitis, wound, and urinary tract infections
(Guzman Prieto et al., 2016). In addition, other enterococcal
species including Enterococcus durans, Enterococcus avium,
Enterococcus gallinarum, Enterococcus casseliflavus, Enterococcus
raffinosus, and Enterococcus hirae have sporadically been
associated with infections in humans (Klein, 2003).
Most of the E. faecium and E. faecalis infections are
opportunistic and are increasingly difficult to treat due to
high rates of resistance to β-lactams, aminoglycosides, and
vancomycin, which are mostly associated with E. faecium strains
(Cattaneo et al., 2010). Similar to resistance genes, virulence
genes are also frequently encoded on mobile elements and
are therefore thought to disseminate frequently via intra-
and interspecies horizontal gene transfer within the genus
Enterococcus (Laverde Gomez et al., 2011). Both E. faecium and
E. faecalis can carry a variety of genes that contribute to virulence
in the immunocompromised patient. For E. faecalis these include
genes encoding aggregation substance (asa1) (Galli and Wirth,
1991), cytolysin (cyl) (Jett et al., 1992), and enterococcal surface
protein (esp-fs) (Vankerckhoven et al., 2004),whereas for E.
faecium genes associated with virulence encode a putative
hyalorunidase (hyl) (Klare et al., 2005) and enterococcal surface
protein (esp-fm) (Hendrickx et al., 2013), among others.
Studies using Multi Locus Sequence Typing (MLST) have
shown that there is a remarkable difference in the population
structure between E. faecalis and E. faecium (Palmer et al., 2014).
The phylogeny of E. faecalis did not reveal clustering of strains
according to their source, e.g., human, clinical, or animal strains
(Guzman Prieto et al., 2016).
In contrast, in E. faecium, high-risk clonal-complexes exist,
which exhibit high levels of antibiotic resistance and are
significantly associated with clinical infections in hospitalized
patients (Leavis et al., 2006; Willems et al., 2012). Genome
sequencing confirmed that the majority of clinical isolates form
a distinct sub-population of E. faecium (Lebreton et al., 2013).
Recently, Tedim et al. (2015) studied the population biology
of intestinal Enterococcus isolates from hospitalized and non-
hospitalized individuals in different age groups. They found that
E. faecium populations differ with respect to the observed clonal
lineages between hospitalized patients and community-based
individuals.
Moreover, the previous identification by whole genome
sequencing of E. faecium isolates of distinct hospital (A1) and
commensal (B) clades suggests that a distinct evolutionary
background exists between commensal and clinical isolates
(Palmer et al., 2012). Likewise, Muruzábal-Lecumberri et al.
(2015) reported a high prevalence of E. faecalis sequence type
(ST) 6 (CC2) in patients undergoing selective decontamination
of the digestive tract and indicated that a rapid detection is
necessary to avoid a dissemination outside intensive care units
(ICUs).
Patients in an ICU are at a high risk for developing nosocomial
infections with multi-drug resistant bacteria and are often
exposed to strong selective antibiotic pressure (Streit et al., 2004).
Several studies have shown that the exposure of patients to broad-
spectrum antibiotics, combined with prolonged hospital stay, can
result in colonization by multi-drug resistant enterococci leading
to nosocomial transmission and infection (Austin et al., 1999;
Carmeli et al., 2002). The prophylactic therapy Selective Digestive
Decontamination (SDD) aims to prevent secondary infection
with opportunistic pathogens, including Enterobacteriaceae,
Staphylococcus aureus and yeasts, in ICU patients and to decrease
mortality (de Smet et al., 2009).
Previous studies have shown that SDD therapy can select for
intestinal colonization by enterococci (Humphreys et al., 1992;
de Smet et al., 2009; Benus et al., 2010). A recent meta-analysis
of van der Bij et al. (2016), determined the antibiotic resistance
rate of Gram-positive cocci in blood and respiratory specimens
in 42 Dutch ICUs in the period from 2008 to 2013, indicating
that prophylactic therapy was not associated with an increase
of antibiotic resistance in Gram-positive cocci. In this study,
we characterized Enterococcus isolates colonizing the intestinal
tract of ICU patients receiving SDD therapy and to evaluate in
more detail the genetic relatedness of E. faecalis and E. faecium
isolates, using MLST and Bayesian analysis of the population
structure (BAPS). Furthermore, we determined carriage of genes
encoding antimicrobial resistance and virulence determinants in
this population.
MATERIALS AND METHODS
Selection of Patients
The patients were selected as part of an approved study
to determine the effects of antibiotic prophylactic therapy
on antibiotic resistance (Buelow et al., 2014). The inclusion
criteria included patients discharged from the ICU who received
SDD for at least 96 h. Exclusion criteria included a hospital
stay and/or antibiotic treatment prior to ICU admission and
discontinuation of SDD before ICU discharge. All patients
included in this study were > 18 years of age. The SDD
protocol was reviewed and approved by the institutional review
board of the University Medical Center Utrecht (Utrecht, The
Netherlands). The SDD protocol comprised the oral application
of 0.5 g of a paste containing 2% tobramycin 2% polymyxin E and
2% amphotericin B, given four times daily. In addition, a 10 ml
suspension containing 80mg tobramycin, 100mg polymyxin E
and 500mg amphotericin B was administered through a gastric
tube four times daily, and cefotaxime (4 × 1,000 mg) was given
intravenously for the first 4 days after ICU admission.
Samples Collection
Fecal samples were collected at different time points during ICU
hospitalization and, for five patients, after ICU discharge and
Frontiers in Microbiology | www.frontiersin.org 2 August 2017 | Volume 8 | Article 1596
Bello Gonzalez et al. Enterococcus Colonization in ICU Patients
cessation of SDD. All the samples were de-identified, received
a sample code, and were subsequently categorized according to
the collection time for subsequent analyses: ICU stay (including
samples collected during ICU hospitalization for up to 40 days,
n = 27), and post-ICU (samples taken after ICU discharge and
discontinuation of SDD, n= 7) (Table 1). Samples were collected
upon defecation and stored at 4◦C for 30 min to 4 h. Two aliquot
of 0.5 g of fecal material were collected, one aliquot was stored
directly−80◦C for fecal DNA isolation, and the other aliquot was
suspended in 5 ml of 20 mM anoxic phosphate buffer (pH 7.0)
with 40% glycerol, and transferred to−80◦C for further analysis.
Bacterial Culture Conditions and Initial
Characterization
Enterococci were isolated on Bile-Esculin Agar (BEA) (Oxoid
B.V., Landsmeer, The Netherlands). Colonies growing on BEA
media were selected based on colony morphology (up to five
colonies per plate) for phenotypic characterization (Winn et al.,
2006). Haemolysis was determined by cultivation on Blood Agar
supplemented with 5% sheep blood (Oxoid) after incubation at
37◦C for 24 h. Isolates that showed phenotypic differences in
antibiotic resistance patterns (see below) were selected for further
characterization.
DNA isolation was performed using the protocol for Gram-
positive bacteria of the QIAamp R© DNA Mini Kit (Qiagen
Benelux B.V., Venlo, The Netherlands). DNA was used for the
identification of the isolates and detection of antibiotic resistance
and virulence genes by Polymerase Chain Reaction (PCR) as
described below. In addition, total bacterial DNA extraction
was performed from 0.5 g of fecal material using the modified
repeated bead beating method previously described (Salonen
et al., 2010) and used for the quantification of the enterococcal
population as described below.
Identification and Classification of Isolates
The complete bacterial 16S ribosomal RNA (rRNA) gene was
amplified from genomic DNA using T7prom-Bact-27-F and
Uni-1492-R primers as described previously (Rajilic´-Stojanovic´
et al., 2009). The amplified fragments were selected for partial
sequence analysis of the 16S rRNA gene (∼800 bp) using the 16S-
1392R primer 5′- ACGGGCGGTGTGTRC -3′ (GATC Biotech,
Cologne, Germany).
Partial 16S rRNA gene sequences of isolates assigned to
other Enterococcus species obtained in this study were deposited
at GenBank under accession numbers KX577731, KX577732,
KX577733, KX577734.
Quantification of the Enterococcal
Population
The enterococcal population present in the fecal material was
quantified by qPCR with 16S rRNA gene targeted enterococci-
specific primers described by Matsuda et al. (2009). A standard
curve was made from bacterial genomic DNA (E. faecium E5),
using 10-fold dilution series (1.0 × 101–1.0 × 109 DNA copies
µl−1). The standard curve had a correlation coefficient of R =
0.97–0.99 and an efficiency of amplification between 97.2 and
103.1%.
The qPCR was performed with the SYBR-Green PCR kit
(Roche Applied Science). The total reaction volume was 10
µl: 5 µl SYBR-Green I, 0.2 µl of each forward and reverse
primers, 1.6µl of sterilized nuclease free water and 3µl extracted
DNA (1 ng/µl). The amplification program included an initial
denaturation step at 94◦C for 5 min, followed by 40 cycles
of denaturation for 20 s at 94◦C, annealing for 20 s at 60◦C
and extension for 50 s at 720C. A melting curve analysis was
performed by slowly heating the sample from 60 to 95◦C (0.5◦C
per 15 s) with simultaneous monitoring of fluorescence. All
reactions were performed in duplicates in a 384- well PCR plate
sealed with optical sealing tape (Bio-Rad) on a iQ5 real-time PCR
detection system.
One way-ANOVA was used for statistical analysis to indicate
significant differences of enterococcal abundance during and
after SDD therapy, with Bonferoni correction (p < 0.05) for
multiple testing.
Antimicrobial Susceptibility
Vancomycin resistance of enterococci was screened on Mueller-
Hinton Agar (MHA) (Oxoid) containing 6 µg/ml vancomycin.
Colonies growing on this medium were tested by E-test
(Biomerieux) to determine the minimal inhibitory concentration
(MIC) of vancomycin, following CLSI guidelines (CLSI, 2013).
In addition, the disk diffusion method was used to test for
susceptibility to ampicillin (10 µg) and tetracycline (30 µg)
(CLSI, 2013).
Detection of Antibiotic Resistance- and
Virulence Factor-Encoding Genes
Antibiotic resistance genes were detected using a multiplex PCR
for the vancomycin-resistance genes van (A), van (B), and van
(C) (van (C1)–van (C2)/van (C3)) (Depardieu et al., 2004), and a
single PCR for erm (A), erm (B), erm (C), and mef (A)/mef (E)
genes (Zou et al., 2011). PCR products of mef (A) and mef (E)
genes were discriminated by BamHI restriction analysis, as only
mef (A) carries a single restriction site, giving rise to fragments
of 284 and 64 bp as described previously (Klaassen and Moutin,
2005).
Genes coding for virulence factors, i.e., enterococcal surface
protein (esp-fm, esp-fs), aggregation substance (asa1), cytolysin
(cyl (B)), and hyalorunidase (hyl), were selected for detection
by PCR as described previously (Vankerckhoven et al., 2004;
Hällgren et al., 2009).
E. faecalis ATCC29212, E. faecium E5 and E. faecalis E507
(Department of Medical Microbiology, Utrecht Medical Centre,
UMC, The Netherlands) and E. gallinarum HSIEG1 (van den
Bogert et al., 2013) (Laboratory of Microbiology, Wageningen
University, The Netherlands) were used as positive controls
for the detection of antibiotic resistance and virulence factor
encoding genes. Amplicons were visualized by agarose gel
electrophoresis.
Clonal Relatedness and Analysis of
Population Structure
In order to establish the clonal relationship of
Enterococcus isolates, we applied the MLST schemes proposed
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TABLE 1 | Overview of the Enterococcus species isolated and characterized per patient during the different time points (ICU stay and Post-ICU).
Patient ID Original
patient
ID*
Sample
collected (days)
Location
of patient
Identification MLST MIC Van
(µg/ml)
Resistance
gene
Virulence
factor
Patient 1 120 3 ICU E. faecalis 589 2 N.A.** N.D.***
3 ICU E. faecalis 589 2 ermB N.D
21 ICU E. faecalis 589 2 N.D N.D
41 Post-ICU E. faecium 78 2 N.D esp
41 Post-ICU E. faecium 78 2 ermB esp
41 Post-ICU E. faecalis 589 2 N.D N.D
Patient 2 105 17 Post-ICU E.sp_1 0.5 ermB N.D
17 Post-ICU E.sp_2 0.5 ermB N.D
17 Post-ICU E.sp_3 16 ermB, vanC1 esp, hyl
Patient 3 108 2 ICU E. faecium 117 0.5 ermB esp
12 ICU E. faecium 117 0.5 ermB esp
27 Post-ICU E. faecalis 81 0.5 ermB asa, esp
Patient 4 157 6 ICU E. faecium 117 1 ermB esp
7 ICU E. faecium 730 1 ermB esp
15 ICU E. faecium 117 1 ermB esp
24 ICU E. faecium 730 1 ermB esp
40 ICU E. faecium 730 1 ermB esp,asa
40 ICU E. faecalis 6 1 ermB esp,asa
40 ICU E. faecalis 6 1 ermB esp
40 ICU E. faecalis 6 1 N.D esp
Patient 5 179 3 ICU E. faecium 117 0.75 ermB esp
3 ICU E. faecium 117 0.75 ermB esp
16 Post-ICU E. faecium 117 0.75 ermB esp
18 Post-ICU E. faecium 117 0.75 ermB esp
16 Post-ICU E.sp_4 0.5 ermB N.D
18 Post-ICU E.sp_5 0.5 N.A esp, asa
Patient 6 165 4 ICU E. faecalis 16 1 ermB esp,asa
16 ICU E. faecalis 16 1.5 ermB esp, asa
Patient 7 180 5 ICU E. faecium 60 0.5 N.A N.D
5 ICU E. faecium 117 1 ermB esp
16 ICU E. faecium 361 1 N.D N.D
Patient 8 169 6 ICU E. faecalis 6 1 ermB asa
6 ICU E. faecalis 6 1 ermB asa,esp
11 ICU E. faecalis 6 1 ermB asa
11 ICU E. faecium 117 1 ermB esp
11 ICU E. faecium 117 1 ermB esp,asa
25 Post-ICU E. faecium 17 1 N.D N.D
25 Post-ICU E. faecium 17 1 N.D N.D
25 Post-ICU E. faecium 17 1 ermB N.D
Patient 9 163 4 ICU E. faecium 117 0.75 N.D N.D
4 ICU E. faecium 730 0.75 ermB esp
*The original code represents the patient assigned number used in previous publications (Buelow et al., 2014, 2017).
**NA, no applicable.
***ND, not detected.
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by Ruiz-Garbajosa et al. (2006) and Homan et al. (2002) or E.
faecalis and E. faecium, respectively.
Sequences were compared with published alleles, and
sequence types (STs) were assigned using the MLST
database (http://pubmlst.org/efaecium/ and http://pubmlst.
org/efaecalis/). BAPS groups were determined as previously
described (Willems et al., 2012). E. faecalis and E. faeciumMLST
products were stored in the MLST database (http://pubmlst.org/
efaecium/ and http://pubmlst.org/efaecalis).
RESULTS
Identification of Intestinal Enterococcus
Isolates from ICU Patients Receiving SDD
A total of nine ICU hospitalized patients that underwent
SDD prophylactic antibiotic therapy were followed. From these
patients, 34 fecal samples were collected. Besides SDD, additional
antibiotics were administrated to seven patients for the control
of infections and/or as an agent to accelerate gastric motility
during ICU stay (Pilot, 1994; Galligan et al., 2005). Enterococci
were isolated from 23 out of 34 fecal samples; the number of
isolates per patient ranged from 2 (patient 6, 9) to 8 (patient 4,
8) (Table 1). Thirty six isolates were classified to the enterococcal
species level by 16S rRNA gene sequencing and MLST products.
The most commonly found species were E. faecium (23 isolates)
and E. faecalis (13 isolates). The remaining five enterococcal
isolates, all of whichwere isolated only during the post-ICU phase
(Figure 1, Table 1), could not be unequivocally identified to the
species level by 16S rRNA gene sequencing. Six patients receiving
SDD developed nosocomial enterococcal infections during ICU
stay (Figure 1), including one pleural infection caused by E.
faecium, six urinary tract infections (two episodes in a single
patient) caused by E. faecalis (five cases) and E. faecium (one
case), and one central line catheter associated infection caused
by E. faecalis (two episodes in a single patient). Unfortunately,
however, the corresponding clinical isolates were not available for
further analysis.
Quantification of the Enterococcal
Population
The quantification of the enterococcal population based on
enterococcal 16S rRNA gene-targeted qPCR showed a significant
increase in time from ICU stay to post ICU (6.0 × 10 6 vs.
2.0 × 10 7 Log DNA copies/g of feces; p <0.05) in seven out
of 9 patients. In the patients, substantial shifts in the absolute
enterococcal 16S rRNA gene copy number were observed during
the hospitalization period (Figure 2).
Antimicrobial Susceptibility
All isolates were vancomycin-susceptible (MIC 0.5–2 µg/ml),
except for a single vancomycin resistant (MIC 16 µg/ml)
isolate closely related to E. gallinarum (E.sp_3) (99% nucleotide
identity).
Ampicillin resistance was detected in 25 out of 41 isolates, with
the highest prevalence of resistant strains being found amongst
E. faecium isolates[21 (91%) E. faecium, three (23%) E. faecalis,
and one (20%) E.sp (E.sp_5)]. Resistance to tetracycline was
detected in 19 out of 41 isolates [9 E. faecalis, seven E. faecium,
and three E. spp. (E.sp_1, E.sp_2, E.sp_4)], the majority of which
was obtained during ICU stay and in one patient during the first
72 h after admission.
Detection of Antibiotic Resistance- and
Virulence Factor-Encoding Genes
The presence of four of the genes that encode macrolide-
lincosamide-streptogramin (MLS) resistance, namely erm (A),
erm (B), erm (C), and mef (A)/mef (E) genes genes encoding
the Major Facilitator Superfamily (MFS) transporter conferring
resistance to erythromycin, were assayed by PCR-based
detection. Our results revealed the presence of the erm (B) gene
in 30 out of 41 enterococci isolates that were obtained during
the entire study period. No other MLSB resistance genes or MFS
transporter genes were detected. From the group of vancomycin
resistance genes tested, the van (C1) gene was identified in the
single isolate that was also found vancomycin resistant (Figure 1,
Table 1).
Three out of the four targeted genes encoding enterococcal
virulence factors were detected. The asa1 gene was frequently
present in E. faecalis isolates (n= 7/13), whereas the esp gene was
more often found in E. faecium isolates (n= 17/23). The esp gene
was also present in two E. sp. isolates. Finally, the hyl gene was
detected post-ICU in a single isolate of E. faecium and in a single
isolate closely related to E. gallinarum (99% nucleotide identity).
All isolates displayed alpha-haemolysis in blood agar. The cyl (B)
gene, which would cause a beta-hemolytic phenotype (Semedo
et al., 2003; Abriouel et al., 2008), was not detected in any of the
isolates (Figure 1).
Clonal Relatedness and Analysis of
Population Structure
Using MLST, we established the clonal relationship of all E.
faecium and E. faecalis isolates obtained in this study. In total,
we identified six different STs among the E. faecium isolates
(Figure 3, Table 2). Further analysis of their population structure
revealed that these STs belonged to three BAPS (sub) groups,
which were previously associated with hospitalized patients
(Willems et al., 2012). The majority of the STs belonged to
BAPS group 2.1a (18 isolates), and 15 of them were resistant
to ampicillin (ST117 n = 12, ST78 n = 2, and ST730 n = 1).
Other sub-groups observed included BAPS 1.2 (2 isolates) as well
as BAPS 3.3a2 (3 isolates). In four patients, we identified two
or more different STs in the same patient during hospitalization
(Figure 3).
Among the E. faecalis isolates, we identified three STs
(ST6, ST81, and ST16), which were previously detected among
hospitalized patients (Willems et al., 2012), as well as a new
ST (ST589), represented by four isolates (Figure 3, Table 2).
All isolates belonging to ST589 were susceptible to ampicillin,
and were obtained from a single patient from samples taken
throughout the study. Three out of these four ST589 isolates
carried the ermB gene.
From the group of E. faecalis isolates belonging to ST6 (n =
6), three carried ermB, asa, and esp genes and were susceptible to
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FIGURE 1 | Overview of the dynamics of colonization by Enterococcus species and carriage of antibiotic resistance and virulence genes during and after ICU
hospitalization. The black dots indicate days where fecal samples were taken during hospitalization. Discontinuation lines (//) indicate samples collected during the
post-ICU period. The different species isolated are indicated by differently colored dots: orange (E. faecalis), green (E. faecium), dark gray (E.sp). Isolates not
connected to a black dot were obtained from the sample closest to the left. The presence of antibiotic resistance genes is indicated by red (ermB) and purple dots
(vanC1). Virulence factors are shown in heptagonal shapes (a-asa1), (e-esp-fm and esp-fs), (h-hyl). Patients that developed nosocomial infections during ICU stay with
E. faecalis and E. faecium are indicated by green (E. faecium) and orange (E. faecalis) triangles. Gray boxes indicate systemic antibiotics given under clinical indications
at the specific time point indicated (ERY, erythromycin; VAN, vancomycin; CPR, ciprofloxacin; CTR, ceftriaxone; CAZ, ceftazidime; CZL, cefazoline; MER, meropenem;
FLX, flucoxacilin; AMX, amoxacillin; CLN, clindamycin; MTZ, metronidazole; MUP, mupirosin), yellow boxes indicate systemic antibiotics given under clinical indications
during the entire ICU stay (CRX, cefuroxime; COT, cotrimoxazole).
ampicillin, whereas the other three isolates displayed resistance
to ampicillin. BAPS cluster analysis subdivided the E. faecalis
isolates into BAPS groups 1 (eight isolates) and 3 (one isolate)
(Table 2). In contrast to the situation in the E. faecium isolates, we
neither detected the simultaneous presence of multiple E. faecalis
STs nor clonal replacement over time within individual patients.
DISCUSSION
In the present study we characterized a group of Enterococcus
species isolated from fecal samples of ICU patients receiving
SDD therapy.We observed a pool of diverse enterococcal species,
being E. faecium and E. faecalis the most prevalent species, both
previously identified as important human pathogens associated
with nosocomial infections (Cattaneo et al., 2010).
In three patients, these two species were detected in samples
collected during the first 72 h, which could suggest that these
patients were colonized with the recovered strains before ICU
admission. This is in line with previous studies, as recently
reviewed by Guzman Prieto and co-authors, showing that
enterococci are present in healthy humans as well as in the
environment, and that the abundance of resistance genes and
mobile elements rapidly increases and facilitates colonization and
subsequent infection in hospitalized patients (Guzman Prieto
et al., 2016).
The clinical isolates causing nosocomial infections in the
patients included in our study were not available for further
analysis, which limited the possibility to clarify whether the
infections derived from the isolates colonizing the patient in that
period, and whether the isolates obtained from fecal material
correspond to a nosocomial acquisition or selection of strains
that were present in the gut microbiota of these patients prior
to hospitalization. Other enterococcal isolates could not be
identified to the species level (n = 5), although it should
be noted that these were found only post-ICU. One possible
explanation could be that due to the cessation of the SDD
therapy, and thus aleviation of the corresponding antibiotic
selective pressure during post-ICU stay, other species than
E. faecalis and E. faecium were able to colonize the gut. From
these isolates, three isolates were closely related to E. gallinarum
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FIGURE 2 | 16S rRNA gene-targeted qPCR based quantification of the enterococcal population present per patient in the samples taken at different time points
[during ICU (D) and Post-ICU (P)].
FIGURE 3 | Sequence types (ST) identified per sample, per patient during and after SDD therapy. The differently colored dots indicate the species: orange (E.
faecalis), green (E. faecium). Numbers indicate the sequence types. Black dots indicate the time point (days) where samples were taken during hospitalization. If
multiple strains were isolated and characterized, these are shown to the right of each indicated timepoint.
and E. avium species. Both species have been identified in
fecal samples of animals and healthy humans (Layton et al.,
2010; Silva et al., 2011), and infrequently linked to human
enterococcal infections (Tan et al., 2010; Varun et al., 2016).
We cannot exclude that these other species were present in
fecal samples taken at earlier time points at very low population
Frontiers in Microbiology | www.frontiersin.org 7 August 2017 | Volume 8 | Article 1596
Bello Gonzalez et al. Enterococcus Colonization in ICU Patients
TABLE 2 | Sequence type (ST) and BAPS analysis of Enterococcus faecalis and
Enterococcus faecium isolates.
Number of
isolates
Sample
collected
(ICU-Post ICU
ST
number
BAPS
group
BAPS
subgroup
E. faecalis
(n = 13)
6 ICU 6 1
2 ICU 16 1
4 3 ICU - 1 Post ICU 589 N.A*
1 Post ICU 81 3
E. faecium
(n = 23)
4 ICU 730 2 2.1a
1 ICU 361 1 1.2
1 ICU 60 1 1.2
12 10 ICU—2 Post
ICU
117 2 2.1a
3 Post ICU 17 3 3.3a2
2 Post ICU 78 2 2.1a
*N.A: Not available.
size and thus evaded detection with the methods used in
this study.
We were furthermore able to isolate more than one
enterococcal species per sample in five out of nine patients.
This highlights the importance of analyzing multiple colonies
per culture to adequately sample the diversity of the enterococcal
population. Moreover, qPCR analysis indicated an increase in the
abundance of enterococci in seven out of nine patients. This shift
could be due to the administration of antibiotics and to changes
in the gut microbiota composition due to the antibiotic selective
pressure. This is in line with previous studies based on qPCR
analyses that showed that the enterococcal population increased
in hospitalized patients receiving antibiotics compared to
hospitalized patients without antibiotics and healthy volunteers
(Bartosch et al., 2004).
Colonization by ampicillin-resistant Enterococcus faecium
(ARE) is frequently associated with previous exposure to selective
antibiotics, and ampicillin resistance is a specific trait for
nosocomial isolates (de Regt et al., 2012).
In our study the highest prevalence of ampicillin resistance
were found in E. faecium isolates compared to non-ampicillin
resistant-E. faecium isolates. Similar results were reported by
Ruiz-Garbajosa P., et al. (2012); indicating that this increased
populationmost significantly contributes to the transmission and
spread of enterococcal resistance in the ICU.
In our study, vancomycin resistance was not detected among
E. faecalis and E. faecium isolates. This is in line with the
previously reported prevalence (<1% for both E. faecium
and E. faecalis) of vancomycin-resistance among enterococci
in clinical infections in the Netherlands, as shown in the
EuropeanAntimicrobial Resistance Surveillance System (EARSS)
(ecdc.europa.eu/en/activities/surveillance/EARS-Net). The only
vancomycin-resistant isolate was identified as being closely
related to E. gallinarum (vancomycin MIC of 16 µg/ml), which
carried the van (C1) gene that is naturally present in this species
(Toye et al., 1997).
Resistance to tetracycline was detected in 46% of all 41
isolates (n = 19) and predominantly in E. faecalis isolates, which
is in accordance with previous studies (Templer et al., 2008).
Moreover, the presence of the macrolide resistance gene erm (B)
was detected in 30 of these isolates (73%). We can not exclude,
however, that other erythromycin resistance genes were present
in these isolates. Although no vancomycin resistant E. faecalis
and E. faecium populations were observed in the current study,
our findings highlight the importance to perform a periodic
surveillance during SDD therapy in ICU patients, in order
to detect resistant Enterococcus spp. strains and prevent their
dissemination as a preventive infection control measure.
Moreover, we observed that the pool of diverse enterococcal
species identified in this study also harbored a variety
of virulence genes that could contribute to infections in
immunocompromised patients. The esp gene was the most
prevalent virulence determinant detected throughout the study
period followed by the asa1 gene detected mainly during ICU
stay, including two E. faecium and seven E. faecalis isolates,
and one isolate closely related to E. avium. Similar results were
previously reported (Billström et al., 2008; Hällgren et al., 2009;
Sharifi et al., 2013). In addition, we detected the presence of the
hyl gene in one E. faecium isolate and one isolate closely related
to E. gallinarum only post-ICU. It should be noted, however,
that the hyl gene has been identified not only in E. faecium
and E. faecalis, but also in E. casseliflavus, E. mundtii, and E.
durans isolated from food-stuffs (Trivedi et al., 2011), showing
that the hyl gene can be present in a variety of Enterococcus
spp. Furthermore, we cannot exclude that isolates obtained here
contain other virulence genes that were not targeted in the
present study.
Finally, the clonal relationship and population structure
(BAPs groups) found in E. faecium and E. faecalis isolates
indicated that the vast majority of our E. faecium isolates
clustered in subgroups 2.1a and 3.3a2, representing separate
hospital lineages that belong to clade A1 that contains most
nosocomial E. faecium isolates (Willems et al., 2012). These BAPS
groups are infrequent in healthy individuals (de Regt et al.,
2012) suggesting that these isolates have been acquired during
hospitalization.
Most E. faecalis isolates (62%) clustered in BAPS group 1, of
which the majority belonged to ST 6 that was previously found in
both hospitalized and non-hospitalized patients (Willems et al.,
2012; Tedim et al., 2015).
In our study we observed the simultaneous presence of STs
and clonal replacement over time among E. faecium isolates
during ICU stay, whereas this was not the case for E. faecalis.
Based on the current data, however, it is unclear whether the
clonal replacement observed in E. faecium isolates was due to
nosocomial strains or populations that were previously present
in lower abundances. Future studies would be needed to test this
hypothesis.
The prevalence of Enterococcus in ICU hospitalized patients,
combined with the carriage of antibiotic resistance and virulence
genes, described in this study, underlines the importance of this
group of organisms as a potential cause of nosocomial infections
in critically ill patients. Particular attention needs to be given
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to ICU patients during SDD therapy, with specific focus on
the increased colonization by enterococci, even in non-endemic
countries, considering that in SDD therapy, the enterococcal
population is not a target group. SDD has been shown to not only
decrease mortality and morbidity, but also to induce changes in
the composition of the gut microbiota of patients (Benus et al.,
2010; Buelow et al., 2014). Here we showed that it may increase
the prevalence and extent of colonization by enterococci and
provide insights into the diversity of the enterococcal strains that
colonize these patients.
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